Tristel Regulatory News (TSTL)

TRISTEL plc

("Tristel" or "the Company")

Trading update

Tristel plc, the manufacturer of infection prevention, contamination control and specialist hygiene products, provides a trading update following the end of its financial year on 30 June 2012.

As a result of a strong performance in late June in all of Tristel's business segments, both in the UK and overseas, the Company achieved revenues ahead of the level previously indicated in its update on 15 June. Results to 30 June 2012 will now show adjusted pre-tax profits in excess of £700,000. At its year-end the Company had cash balances of £600,000. Tristel intends to announce its preliminary results for the year to 30 June on 29 October 2012.

 As reported in the earlier update, the Company changed its business model for the UK veterinary market during the second half of the year. In June, the first of the three major national wholesalers listed the Company's "Anistel" product range. The Company is pleased to report that during July the other two wholesalers have also ordered and been supplied with Anistel products. This is an encouraging milestone for the Company as it seeks to establish Anistel as the dominantbrand in the UK veterinary market. Anistel is the successor brand-name to "Trigene" which has been the market leader for the past decade and which has been manufactured by Tristel since 2009. Alongside these developments, six RSPCA regional branches and the Royal Veterinary College have joined a growing list of veterinary practices that are switching to Anistel. 

Paul Swinney, Chief Executive, comments "We are pleased with the progress we are making in establishing direct relationships with the three major national wholesalers who together represent the main distribution route into the UK veterinary market." 

 For further information please contact: